NCT06065267View on ClinicalTrials.gov

Levofloxacin Concomitant Versus Levofloxacin Sequential

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

sequential

amoxicillin 1000 mg bid ,esomprazole 20 bid for one week then levofloxacine 500 mg q.d, metraonidazoel 500 500 bid, and esomprazole 20 bid for one week

DRUG

Levofloxacin 500Mg Oral Tablet

Levofloxacin 500 mg qd, amoxicillin 500 2cab bid,Tinadizole 500 bid, esomprazole 20 bid

Trial Locations (1)

Unknown

General Assembly of Damascus Hospital, Damascus

All Listed Sponsors
lead

Damascus Hospital

OTHER